The deal would establish a foothold in Germany for medical cannabis sales across 1,200 pharmacies and the distribution of pharmaceutical products across 28 countries.
Flora Growth grows, cultivates, and develops products derived from medicinal cannabis that are sold to pharmacies, clinics, and cosmetic businesses worldwide.
Medical marijuana derivatives are included in the expansive resolution for the first time, though some private insurers had already included cannabis trreatments.
Flora Growth Corp (NASDAQ: FLGC) last month became the first ever cannabis cultivator to list on the NASDAQ stock exchange in the US without using a SPAC (Special Purpose Acquisition Company), reverse merger, or dual listing, and became the first all-outdoor cannabis grower to...